Pacifica Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-91
Closed -$25K 508
2025
Q2
$25K Sell
91
-10
-10% -$2.72K 0.01% 258
2025
Q1
$27.1K Sell
101
-17
-14% -$4.19K 0.01% 239
2024
Q4
$27.4K Hold
118
0.01% 246
2024
Q3
$26K Hold
118
0.01% 269
2024
Q2
$23.1K Hold
118
0.01% 286
2024
Q1
$25.4K Hold
118
0.01% 277
2023
Q4
$25.8K Hold
118
0.01% 276
2023
Q3
$24.5K Sell
118
-9
-7% -$1.79K 0.01% 262
2023
Q2
$23.3K Buy
127
+39
+44% +$7.21K 0.01% 232
2023
Q1
$17.1K Buy
+88
New +$15.9K 0.01% 257

Other funds holding CME

Pacifica Partners's CME Position: Q3 2025 in Review

Pacifica Partners sold out of CME Group (CME) in Q3 2025, closing a stake of 91 shares — an estimated $25K sold.

Pacifica Partners first reported a position in CME in Q1 2023 and held it in 10 quarters. The position peaked at $27.4K in Q4 2024. 1,653 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • Pacifica Partners reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
  • Pacifica Partners sold 91 CME Group shares in Q3 2025, an estimated $25K.
  • Pacifica Partners first reported a position in CME Group in Q1 2023 and held it in 10 quarters.
  • Pacifica Partners's CME Group position peaked at $27.4K in Q4 2024.
  • 1,653 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Pacifica Partners's 13F filing for Q3 2025, filed 9 Oct 2025.